Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-06 01:58:38 - browse：64

STAT's Megan Molteni speaks with Feng Zhang in New York on March 21, 2024 — Scientist Feng Zhang, right, is interviewed by reporter Megan Molteni at STAT's Breakthrough Summit East. STAT

When the first biotech companies emerged to capitalize on the revolutionary genome-editing technology CRISPR, Editas Medicine seemed like the pacesetter. It locked up some of the crucial IP, and had behind it the pioneering scientist Feng Zhang of the Broad Institute as one of its founders.

But now, a decade later, Editas is seen as lagging behind its peers. CRISPR Therapeutics, in partnership with Vertex Pharmaceuticals, won the race to get the first CRISPR-based medicine across the finish line. Intellia Therapeutics was the first to show that CRISPR editing could be performed inside the body. Editas, meanwhile, has seen a revolving door among its executives.

So what happened?

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Glen Campbell's doctor discusses his public struggle with Alzheimer's

knowledge

WSS

Data integrity in scientific journals requires "effort" by publishers, institutions

Experts study whether long Covid risk adds up with each reinfection

STAT Virtual Event: Putting AI to the Test

Biotech lab space demand falls sharply

Helping hospitals and community health centers plan for resilience

Thermo Fisher plant for manufacturing gene therapies to expand

focus

Wikipedia

leisure time

What does generative AI mean for health care? We asked experts

Case highlights the risks of experimental stem cell therapy

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

What Congress can do to address the rural doctor shortage

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readers respond to H5N1 and livestock movements, and more

Dobbs anniversary: the lost opportunity of abortion as health care

Readers respond to H5N1 and livestock movements, and more

Medicare proposal to cover medical devices draws a mixed reaction

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

knowledge

Intarcia’s device

Readout LOUD podcast: possible new ALS drug, artificial wombs

Second xenotransplant done with gene

Venture capitalist Bob Kocher on the state of digital health

Glen Campbell's doctor discusses his public struggle with Alzheimer's

With measles on the rise, a personal story of a devastating disease

Wikipedia

knowledge

knowledge

focus